Curtana Pharmaceuticals Company
Curtana is a biopharmaceutical company that has developed therapies for the treatment of the most aggressive types of brain cancer.
Technology:
Small Molecules
Funding Status:
Seed
Investor Type:
Seed
Investors Number:
3
Employee Number:
1-10
Last Funding Date:
2017
Headquarters:
Austin, Texas, United States
Last Funding Type:
Grant
Total Funding:
52288
Founded Date:
2013
Industry:
Biopharma, Biotechnology, Pharmaceutical
Estimated Revenue:
Less than $1M